ASX:PYCBiotechs
How A$584 Million Equity Raise and Larger Share Base Will Impact PYC Therapeutics (ASX:PYC) Investors
PYC Therapeutics Limited recently completed a follow-on equity offering raising about A$584.14 million, issuing multiple tranches of ordinary shares at A$1.50 each, including a rights issue and subsequent direct listing on the ASX.
The capital raise, combined with the recent half-year results showing lower revenue and a reduced net loss, materially reshapes PYC’s funding profile and ownership structure as it progresses its therapeutic programs.
We’ll now examine how this large equity...